NCT02689986View on ClinicalTrials.gov

Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Cold Agglutinin DiseaseAutoimmune Hemolytic Anemia
Interventions
DRUG

Bendamustine, Rituximab

Bendamustine, Rituximab

Trial Locations (8)

Unknown

Herlev University Hospital, Copenhagen

Turku University Hospital, Turku

Akershus University Hospital, Nordbyhagen

NO-5021

Haukeland University Hospital, Bergen

NO-3000

Vestre Viken Hospital, Drammen

NO-5504

Haugesund Hospital, Haugesund

NO-0027

Oslo University Hospital, Oslo

NO-7006

St Olav University Hospital, Trondheim

All Listed Sponsors
lead

Helse Fonna

OTHER

NCT02689986 - Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease | Biotech Hunter | Biotech Hunter